Trial Profile
The Tolerability and Efficacy of Rapid Infliximab Infusions in Patients with Inflammatory Bowel Disease.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Nov 2015
Price :
$35
*
At a glance
- Drugs Infliximab (Primary)
- Indications Inflammatory bowel diseases
- Focus Therapeutic Use
- 02 Nov 2015 New trial record
- 06 Oct 2015 Results published online in Digestive Diseases and Sciences.